We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$181M
AUM Growth
-$73.3M
Cap. Flow
-$69.5M
Cap. Flow %
-38.41%
Top 10 Hldgs %
83.81%
Holding
78
New
26
Increased
38
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$37.9M
2
WFC icon
Wells Fargo
WFC
+$18.8M
3
STNE icon
StoneCo
STNE
+$15.5M
4
AFYA icon
Afya
AFYA
+$8.01M
5
PAGS icon
PagSeguro Digital
PAGS
+$5.27M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.46%
2 Technology 22.93%
3 Financials 12.38%
4 Healthcare 11.33%
5 Consumer Staples 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
26
BeOne Medicines Ltd
ONC
$39.4B
$684K 0.38%
5,585
+1,220
+28% +$162K
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.32T
$610K 0.34%
+10,000
New +$592K
MDLZ icon
28
Mondelez International
MDLZ
$79.9B
$589K 0.33%
+10,648
New +$583K
ELV icon
29
Elevance Health
ELV
$85.5B
$587K 0.32%
2,446
+47
+2% +$12.9K
PFE icon
30
Pfizer
PFE
$153B
$576K 0.32%
16,896
+327
+2% +$11.9K
CSX icon
31
CSX Corp
CSX
$93.1B
$548K 0.3%
+23,721
New +$552K
DHR icon
32
Danaher
DHR
$144B
$537K 0.3%
4,194
+84
+2% +$10.5K
A icon
33
Agilent Technologies
A
$41.2B
$524K 0.29%
6,838
+134
+2% +$9.67K
SAGE
34
DELISTED
Sage Therapeutics
SAGE
$505K 0.28%
3,601
+71
+2% +$11.9K
IWD icon
35
iShares Russell 1000 Value ETF
IWD
$83.7B
$502K 0.28%
+3,913
New +$497K
CI icon
36
Cigna
CI
$74.6B
$500K 0.28%
3,294
+65
+2% +$10.6K
META icon
37
Meta Platforms (Facebook)
META
$1.51T
$463K 0.26%
2,600
-47,400
-95% -$9.01M
NSC icon
38
Norfolk Southern
NSC
$75.1B
$453K 0.25%
+2,520
New +$464K
LLY icon
39
Eli Lilly
LLY
$1.06T
$451K 0.25%
4,036
+79
+2% +$8.79K
HCA icon
40
HCA Healthcare
HCA
$89.5B
$408K 0.23%
3,387
+67
+2% +$8.66K
LH icon
41
Labcorp
LH
$25.9B
$389K 0.22%
+2,697
New +$394K
AMRN
42
Amarin Corp
AMRN
$303M
$378K 0.21%
1,246
+225
+22% +$78.5K
FICO icon
43
Fair Isaac
FICO
$22.5B
$374K 0.21%
+1,231
New +$417K
BMRN icon
44
BioMarin Pharmaceuticals
BMRN
$12.4B
$369K 0.2%
5,478
+809
+17% +$62.3K
MRK icon
45
Merck
MRK
$318B
$349K 0.19%
4,347
+85
+2% +$6.81K
AZN icon
46
AstraZeneca
AZN
$250B
$338K 0.19%
3,793
+77
+2% +$6.68K
ASND icon
47
Ascendis Pharma A/S
ASND
$16.8B
$324K 0.18%
3,360
+379
+13% +$42.3K
HOLX
48
DELISTED
Hologic
HOLX
$306K 0.17%
6,059
+118
+2% +$5.81K
HUM icon
49
Humana
HUM
$46.2B
$292K 0.16%
1,141
+22
+2% +$6.17K
GHDX
50
DELISTED
Genomic Health, Inc.
GHDX
$289K 0.16%
+4,266
New +$293K

Similar funds

JGP Global Gestao de Recursos's Q3 2019 Portfolio in Review

As of Q3 2019, JGP Global Gestao de Recursos held 78 positions worth $181M, down 29% from $254M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $69.5M in Q3 2019, closing 9 positions and reducing 5 holdings. Its most notable exit was Linx S.A., an estimated $5.83M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 9% a quarter earlier, followed by Technology and Financials.

Against the trend, JGP Global Gestao de Recursos opened a new position in Wells Fargo worth $20.2M.

  • JGP Global Gestao de Recursos's largest Q3 2019 buy was Wells Fargo: 400,000 shares worth $20.2M.
  • JGP Global Gestao de Recursos added most to Mercado Libre in Q3 2019, an estimated $37.9M increase.
  • JGP Global Gestao de Recursos's biggest Q3 2019 reduction was Vale, cutting an estimated $15.8M.
  • JGP Global Gestao de Recursos fully exited Linx S.A. in Q3 2019, selling an estimated $5.83M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 84% of its $181M portfolio in Q3 2019.
  • JGP Global Gestao de Recursos opened 26 new positions and closed 9 in Q3 2019.
  • JGP Global Gestao de Recursos's portfolio value fell 29% quarter-over-quarter to $181M.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2019, filed 29 Oct 2019.